Krum H - Search Results

1

RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.

Savira F, Edgley AJ, Jucker BM, Willette RN, Krum H, Kelly DJ, Kompa AR, Wang BH. Savira F, et al. Among authors: krum h. Int J Cardiol. 2021 Jan 15;323:260. doi: 10.1016/j.ijcard.2020.09.021. Epub 2020 Sep 10. Int J Cardiol. 2021. PMID: 32920075 No abstract available.

2

Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.

Tzanidis A, Hannan RD, Thomas WG, Onan D, Autelitano DJ, See F, Kelly DJ, Gilbert RE, Krum H. Tzanidis A, et al. Among authors: krum h. Circ Res. 2003 Aug 8;93(3):246-53. doi: 10.1161/01.RES.0000084382.64418.BC. Epub 2003 Jul 3. Circ Res. 2003. PMID: 12842917

3

The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.

Gilbert RE, Krum H, Wilkinson-Berka J, Kelly DJ. Gilbert RE, et al. Among authors: krum h. Diabet Med. 2003 Aug;20(8):607-21. doi: 10.1046/j.1464-5491.2003.00979.x. Diabet Med. 2003. PMID: 12873287 Review.

4

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure.

Lim M, Honisett S, Sparkes CD, Komesaroff P, Kompa A, Krum H. Lim M, et al. Among authors: krum h. Circulation. 2004 Mar 16;109(10):1212-4. doi: 10.1161/01.CIR.0000121326.69153.98. Epub 2004 Mar 8. Circulation. 2004. PMID: 15007012

5

Cardiovascular role of urotensin II: effect of chronic infusion in the rat.

Kompa AR, Thomas WG, See F, Tzanidis A, Hannan RD, Krum H. Kompa AR, et al. Among authors: krum h. Peptides. 2004 Oct;25(10):1783-8. doi: 10.1016/j.peptides.2004.03.029. Peptides. 2004. PMID: 15476946 Review.

6

p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.

See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H. See F, et al. Among authors: krum h. J Am Coll Cardiol. 2004 Oct 19;44(8):1679-89. doi: 10.1016/j.jacc.2004.07.038. J Am Coll Cardiol. 2004. PMID: 15489104 Free article.

7

Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta.

Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krum H, Wilkinson-Berka J, Gilbert RE. Martin J, et al. Among authors: krum h. Cardiovasc Res. 2005 Feb 15;65(3):694-701. doi: 10.1016/j.cardiores.2004.10.041. Cardiovasc Res. 2005. PMID: 15664396

8

Fibrosis as a therapeutic target post-myocardial infarction.

See F, Kompa A, Martin J, Lewis DA, Krum H. See F, et al. Among authors: krum h. Curr Pharm Des. 2005;11(4):477-87. doi: 10.2174/1381612053382098. Curr Pharm Des. 2005. PMID: 15725066 Review.

9

Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction.

Boyle AJ, Kelly DJ, Zhang Y, Cox AJ, Gow RM, Way K, Itescu S, Krum H, Gilbert RE. Boyle AJ, et al. Among authors: krum h. J Mol Cell Cardiol. 2005 Aug;39(2):213-21. doi: 10.1016/j.yjmcc.2005.03.008. J Mol Cell Cardiol. 2005. PMID: 15878171

10

Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.

Sondermeijer B, Kompa A, Komesaroff P, Krum H. Sondermeijer B, et al. Among authors: krum h. Am J Hypertens. 2005 Sep;18(9 Pt 1):1195-9. doi: 10.1016/j.amjhyper.2005.03.748. Am J Hypertens. 2005. PMID: 16182109 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

590 results

Search Page

Filters